|
SAMD8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.94650000141206E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.46999999950381E-08 |
| Normal-vs-Stage2 |
5.840100E-04 |
| Normal-vs-Stage3 |
2.337600E-03 |
| Normal-vs-Stage4 |
6.209900E-02 |
| Stage1-vs-Stage2 |
3.775800E-01 |
| Stage1-vs-Stage3 |
2.494400E-01 |
| Stage1-vs-Stage4 |
5.452000E-01 |
| Stage2-vs-Stage3 |
9.030800E-01 |
| Stage2-vs-Stage4 |
9.809000E-01 |
| Stage3-vs-Stage4 |
9.131600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.11720000315086E-08 |
| Normal-vs-AfricanAmerican |
1.50129999999526E-05 |
| Normal-vs-Asian |
2.120300E-03 |
| Caucasian-vs-AfricanAmerican |
8.620000E-01 |
| Caucasian-vs-Asian |
7.616000E-01 |
| AfricanAmerican-vs-Asian |
7.351400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.80850906367414E-12 |
| Normal-vs-Female |
7.256800E-03 |
| Male-vs-Female |
6.823200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.51720000000277E-05 |
| Normal-vs-Extreme_Weight |
2.52564635871977E-12 |
| Normal-vs-Obese |
1.613400E-04 |
| Normal-vs-Extreme_Obese |
1.012150E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.728790E-01 |
| Normal_Weight-vs-Obese |
4.354800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.397800E-01 |
| Extreme_Weight-vs-Obese |
5.617300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.133600E-01 |
| Obese-vs-Extreme_Obese |
3.004600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.769600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.55687999999765E-05 |
| Normal-vs-Age(61-80Yrs) |
4.21019996643679E-10 |
| Normal-vs-Age(81-100Yrs) |
2.78589999958001E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.888600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.259200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.352100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.817800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.956800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.409900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.46733794190868E-12 |
| Normal-VS-Type2 PRCC |
1.90519999998529E-06 |
| Normal-VS-KIRP CIMP |
8.627600E-01 |
| Normal-VS-Unclassified PRCC |
7.478500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.803760E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.365900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.437600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.735500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.224560E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.776300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.05380004722377E-09 |
| Normal-vs-N1 |
1.658350E-02 |
| Normal-vs-N2 |
4.819200E-01 |
| N0-vs-N1 |
1.261040E-01 |
| N0-vs-N2 |
5.957200E-01 |
| N1-vs-N2 |
9.344200E-01 |
|
|
